Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population by Sumithira Vasu,

Slides:



Advertisements
Similar presentations
The role of post granulocyte colony-stimulating factor white blood cell counts in predicting the mobilization adverse events and yields Shu-Huey Chen1,2.
Advertisements

The Impact of Circulation Access in Allogeneic Peripheral Blood Stem Cell Harvest Shang-Hsien Yang1, Tso-Fu Wang2,3, Shu-Hui Wen4, Sung-Chao Chu3, Ruey-Ho.
Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience.
Lako S, Daka A, Nurka T, Dedej T, Memishaj S
Erin F. Wolff, M. D. , Naoya Uchida, M. D. , Ph. D. , Robert E
A phase 1 trial of the Fc-engineered CD19 antibody XmAb5574 (MOR00208) demonstrates safety and preliminary efficacy in relapsed CLL by Jennifer A. Woyach,
BK Viremia Precedes Hemorrhagic Cystitis in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation  Benjamin L. Laskin, Michelle Denburg,
Immune Reconstitution in Recipients of Photodepleted HLA-Identical Sibling Donor Stem Cell Transplantations: T Cell Subset Frequencies Predict Outcome 
Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular.
by Frederique Ponchel, Ann W. Morgan, Sarah J
Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival by Kai-Da Wu, Lisa.
by Venetia Bigley, Laura E. Spence, and Matthew Collin
Reduced tumor load in peripheral blood after treatment with G-CSF and chemotherapy in children with tumors of the Ewing sarcoma family but not neuroblastoma.
Successful Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant in an Acute Leukemia Patient With Chemotherapy-Induced Marrow Aplasia and Progressive.
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.
Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program by Michael.
Serum Levels of Substance P Are Elevated in Patients With Sickle Cell Disease and Increase Further During Vaso-Occlusive Crisis by Lisa A. Michaels, Kwaku.
Long-term expansion of effector/memory Vδ2− γδ T cells is a specific blood signature of CMV infection by Vincent Pitard, David Roumanes, Xavier Lafarge,
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia by Gerald G. Wulf, Rui-Yu Wang, Ingrid Kuehnle, Douglas Weidner, Frank.
Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation by George E. Georges, Rainer Storb, Jennifer.
Apoptotic Donor Leukocytes Limit Mixed-Chimerism Induced by CD40-CD154 Blockade in Allogeneic Bone Marrow Transplantation  Jian-ming Li, John Gorechlad,
Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen– Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up.
Distinct but phenotypically heterogeneous human cell populations produce rapid recovery of platelets and neutrophils after transplantation by Alice M.
Recovery and Safety Profiles of Marrow and PBSC Donors: Experience of the National Marrow Donor Program  John P. Miller, Elizabeth H. Perry, Thomas H.
by Kenneth Weinberg, Bruce R. Blazar, John E
Donor-Derived Natural Killer Cells Infused after Human Leukocyte Antigen– Haploidentical Hematopoietic Cell Transplantation: A Dose-Escalation Study  Inpyo.
Up-regulation of NK Cell Activating Receptors Following Allogeneic Hematopoietic Stem Cell Transplantation under a Lymphodepleting Reduced Intensity Regimen.
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia  Robert Iannone, James F Casella, Ephraim.
Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 
Combined CD4+ Donor Lymphocyte Infusion and Low-Dose Recombinant IL-2 Expand FOXP3+ Regulatory T Cells following Allogeneic Hematopoietic Stem Cell Transplantation 
The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male.
Unique Abnormalities of CD4+ and CD8+ Central Memory Cells Associated with Chronic Graft-versus-Host Disease Improve after Extracorporeal Photopheresis 
Evidence Supporting Idarucizumab for the Reversal of Dabigatran
Vaccination regimens incorporating CpG-containing oligodeoxynucleotides and IL-2 generate antigen-specific antitumor immunity from T-cell populations undergoing.
Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before.
Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study by Daniel J. DeAngelo, Wendy.
In vitro migratory capacity of CD34+ cells is related to hematopoietic recovery after autologous stem cell transplantation by Carlijn Voermans, Marisha.
Volume 3, Issue 4, Pages (October 2008)
Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD by Nelli Bejanyan, Claudio G. Brunstein,
Potential diagnostic utility of intermittent administration of short-acting gonadotropin- releasing hormone agonist in gonadotropin deficiency  Carrie.
by Hideki Yoshioka, Hiromi Sato, Hiroto Hatakeyama, and Akihiro Hisaka
Phase I/II Study of Intravenous Plerixafor Added to a Mobilization Regimen of Granulocyte Colony–Stimulating Factor in Lymphoma Patients Undergoing Autologous.
Sandra Miklos, Gunnar Mueller, Yayi Chang, Thomas E. O
Retrospective analysis of capillary hemoglobin recovery in nearly 1 200 000 blood donor returns by Pia Niittymäki, Mikko Arvas, Antti Larjo, Pirkko Mattila,
Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase.
Comparison of absolute counts for a, b) white blood cells (WBC), c, d) neutrophils, e, f) monocytes, and g, h) eosinophils for 100 patients with lymphangioleiomyomatosis.
by J. Michael Soucie, Paul E. Monahan, Roshni Kulkarni, Barbara A
Normal Immunologic Response to a Neoantigen, Bacteriophage ΦX-174, in Baboons With Long-Term Lymphohematopoietic Reconstitution From Highly Purified CD34+
Hematopoietic Engraftment in Recipients of Unrelated Donor Umbilical Cord Blood Is Affected by the CD34+ and CD8+ Cell Doses  Seitaro Terakura, Eiichi.
Efficacy of CD34+ Stem Cell Dose in Patients Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation after Total Body Irradiation  Anurag K.
Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients by Erica B. Esrick, John P. Manis,
2-O, 3-O desulfated heparin mitigates murine chemotherapy- and radiation-induced thrombocytopenia by Elizabeth Tkaczynski, Abinaya Arulselvan, John Tkaczynski,
Effective Dose From MPI by Geographic Region Stratified by Gender Box and whisker plots illustrating the median effective dose for women and men in each.
Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease by Jennifer S. Whangbo, Haesook.
A Randomized Controlled Trial to Compare Once- versus Twice-Daily Filgrastim for Mobilization of Peripheral Blood Stem Cells from Healthy Donors  Yukiko.
by Nicholas J. Laping, Michael P. DeMartino, Joshua E
Immune Reconstitution in Recipients of Photodepleted HLA-Identical Sibling Donor Stem Cell Transplantations: T Cell Subset Frequencies Predict Outcome 
Predicted number of joint bleeds according to factor activity level and age group for patients with hemophilia A or B based on a regression model. Predicted.
Effect of Weight and Maturation on Busulfan Clearance in Infants and Small Children Undergoing Hematopoietic Cell Transplantation  Radojka M. Savic, Morton.
Statistical evaluation of CD56+ NK cell subset data.
A population-based longitudinal study on the implication of demographic changes on blood donation and transfusion demand by Andreas Greinacher, Kerstin.
Donation Activities and Product Integrity in Unrelated Donor Allogeneic Hematopoietic Transplantation: Experience of the National Marrow Donor Program 
Figure 1 Peripheral blood lymphocyte counts during dose titrationB-lymphocyte (CD19+; A) and total lymphocyte (CD45+; B) counts (cells/µL) in peripheral.
Mean decline in grip strength with aging by baseline quartile of fasting plasma glucose (FPG). Mean decline in grip strength with aging by baseline quartile.
Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.
Yuri Fedoriw, T. Danielle Samulski, Allison M. Deal, Cherie H
Pain. Pain. (A) Skeletal pain experienced by bone marrow (BM) and peripheral blood stem cell (PBSC) donors at baseline, during the pericollection period,
by Andrew L. Gilman, Michael J
Optimal Donor Selection: Beyond HLA
Graft Monocytic Myeloid-Derived Suppressor Cell Content Predicts the Risk of Acute Graft-versus-Host Disease after Allogeneic Transplantation of Granulocyte.
Presentation transcript:

Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population by Sumithira Vasu, Susan F. Leitman, John F. Tisdale, Matthew M. Hsieh, Richard W. Childs, A. John Barrett, Daniel H. Fowler, Michael R. Bishop, Elizabeth M. Kang, Harry L. Malech, Cynthia E. Dunbar, Hanh M. Khuu, Robert Wesley, Yu Y. Yau, and Charles D. Bolan Blood Volume 112(5):2092-2100 September 1, 2008 ©2008 by American Society of Hematology

Peripheral blood CD34+ cell count after G-CSF administration (10 μg/kg per day) versus weight and age according to donor self-described ethnicity. Peripheral blood CD34+ cell count after G-CSF administration (10 μg/kg per day) versus weight and age according to donor self-described ethnicity. Peripheral blood CD34+ cell counts after G-CSF administration were strongly associated with weight in all ethnic groups. When plotted against donor weight (A), CD34+ cell counts were highest in donors who were Asian/Pacific (◇, short alternating with long dashed line), followed by blacks (▲, dashed line), Hispanic (●, dotted line), and then whites (□, solid line). There was a modest, negative association of CD34+ cell counts when plotted vs donor age (B); the lowest values were observed in white donors and higher values in those who were black, Hispanic, or Asian/Pacific. Sumithira Vasu et al. Blood 2008;112:2092-2100 ©2008 by American Society of Hematology

Associations of peripheral blood CD34+ cell count after G-CSF administration and weight according to G-CSF dose per kg donor weight and total amount of G-CSF received. Associations of peripheral blood CD34+ cell count after G-CSF administration and weight according to G-CSF dose per kg donor weight and total amount of G-CSF received. Peripheral blood CD34+ cell counts plotted against donor weight (A) were significantly higher in donors who received G-CSF at 16 μg/kg per day given as 8 μg/kg per day twice a day (○, dashed line) than in donors who received 10 μg/kg per day (♦, solid line). In contrast, peripheral blood CD34+ cell counts after G-CSF administration plotted against the total dose of G-CSF received (B) were similar in donors who received G-CSF at either 16 μg/kg per day given as 8 μg/kg per day twice a day (○, dashed line) or 10 μg/kg per day (♦, solid line), suggesting that the total amount of G-CSF received exerts a larger impact on CD34+ mobilization than the dose of G-CSF administered per kilogram of donor weight. Sumithira Vasu et al. Blood 2008;112:2092-2100 ©2008 by American Society of Hematology

Associations of peripheral blood CD34+ cell count after G-CSF administration (10 μg/kg per day) according to baseline pre–G-CSF blood platelet count and total mononuclear cell count. Associations of peripheral blood CD34+ cell count after G-CSF administration (10 μg/kg per day) according to baseline pre–G-CSF blood platelet count and total mononuclear cell count. Peripheral blood CD34+ cell counts after G-CSF were higher in donors with higher pre–G-CSF blood platelet counts (A) and total mononuclear cell counts (B). In panels A and B, the response was steepest in Asian/Pacific donors (◇, short alternating with long dashed trend line). Lower responses were observed in white donors (□, solid trend lines) with intermediate levels in blacks (▲, dashed trend line) and Hispanic (●, dotted trend line) donors. Sumithira Vasu et al. Blood 2008;112:2092-2100 ©2008 by American Society of Hematology

Peripheral blood CD34+ cell count after administration of G-CSF versus body weight. Peripheral blood CD34+ cell count after administration of G-CSF versus body weight. Peripheral blood CD34+ cell counts after G-CSF administration at 10 μg/kg per day were higher in donors who underwent (▲, solid trend line) collection of donor lymphocytes by large-volume leukapheresis before G-CSF administration compared with those who did not (◇, dashed trend line) undergo lymphocyte collection before the initiation of G-CSF administration. Data above are for those donors who underwent lymphocyte collection within 2 days of starting G-CSF. Sumithira Vasu et al. Blood 2008;112:2092-2100 ©2008 by American Society of Hematology

Peripheral blood peak CD34+ cell count in male (□, dashed trend line) and female (●, solid trend line) white donors after 10 μg/kg per day G-CSF according to pre G-CSF platelet count, height, and total amount of G-CSF received. Peripheral blood peak CD34+ cell count in male (□, dashed trend line) and female (●, solid trend line) white donors after 10 μg/kg per day G-CSF according to pre G-CSF platelet count, height, and total amount of G-CSF received. As shown in panel A, white females (F) had lower mean post–G-CSF CD34+ cell counts than males (M; mean, 69 vs 83/μL, P = .007; median, 66 vs 76/μL). The horizontal line represents the median, the box the 25th percentile, and the whiskers the 75th percentile. Female donors also had lower CD34+ responses than male donors when plotted against the pre–G-CSF platelet count (B) and height (C); these associations were mitigated by the fact that, on average, women had higher pre–G-CSF platelet counts and lower height than men. When plotted against total G-CSF received, CD34+ responses were similar in men and women (D). Sumithira Vasu et al. Blood 2008;112:2092-2100 ©2008 by American Society of Hematology